Noninvasive Diagnostic Techniques in Determination of Site of Lesion of Auditory Neuropathy Spectrum Disorder
NCT ID: NCT05666466
Last Updated: 2022-12-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
25 participants
OBSERVATIONAL
2022-12-01
2024-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
case group
age between 12 to 50 disproportionate SRS to PTA level presence of OAE presence of CM Normal MRI and CT
extratympanic electrocochleograhy
electrophysiological test
control group
age and sex matched to study group Normal hearing sensitivity and excellent speech discrimination no CAPD
extratympanic electrocochleograhy
electrophysiological test
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
extratympanic electrocochleograhy
electrophysiological test
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* presnce ol lesions in CT or MRI
12 Years
50 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sohag University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Rania Fattouh Ahmad Khalil
Principal investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sohag Faculty of Medicine
Sohag, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Mohammed Abdel Gaffar, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Soh-Med-22-12-16
Identifier Type: -
Identifier Source: org_study_id